The relationship between duration of psoriasis, vascular inflammation, and cardiovascular events Alexander Egeberg, MD, PhD, Lone Skov, MD, PhD, DMSc, Aditya A. Joshi, MD, Lotus Mallbris, MD, PhD, Gunnar H. Gislason, MD, PhD, Jashin J. Wu, MD, Justin Rodante, PA-C, Joseph B. Lerman, MD, Mark A. Ahlman, MD, Joel M. Gelfand, MD, MSCE, Nehal N. Mehta, MD, MSCE Journal of the American Academy of Dermatology Volume 77, Issue 4, Pages 650-656.e3 (October 2017) DOI: 10.1016/j.jaad.2017.06.028 Copyright © 2017 American Academy of Dermatology, Inc. Terms and Conditions
Fig 1 Nelson-Aalen cumulative hazards graph of the population cohort. Major adverse cardiovascular event risk in patients with psoriasis stratified on the basis of disease duration less (n = 57,941) or more than 10 years (n = 29,220) compared with in the general population (n = 4,234,793). Journal of the American Academy of Dermatology 2017 77, 650-656.e3DOI: (10.1016/j.jaad.2017.06.028) Copyright © 2017 American Academy of Dermatology, Inc. Terms and Conditions
Fig 2 Association between vascular inflammation and psoriasis disease duration in the National Institutes of Health cohort. Unadjusted and fully adjusted regression plots demonstrate a direct association between psoriasis disease duration and vascular inflammation in the National Institutes of Health cohort beyond traditional cardiovascular risk factors. Journal of the American Academy of Dermatology 2017 77, 650-656.e3DOI: (10.1016/j.jaad.2017.06.028) Copyright © 2017 American Academy of Dermatology, Inc. Terms and Conditions